Profile: TD2 Inc. specializes in providing oncology treatments to cancer. Cell viability assays are available to quantify growth inhibitory effects of experimental agents, evaluate interactions between convention chemotherapy and experimental agents, and determine optimal drug sequencing. Both low and high-throughput screening are available. We utilize Tecan D300 digital dispenser to provide accurate and repeatable delivery of small molecule and biomolecules. The Tecan D300 allows for completion of simple titrations to complex combination schemes. Our real-time patient identification and selection strategies and tools give clients compounds and patients the greatest chance of success, even in the earliest stages of clinical development.
6 Products/Services (Click for related suppliers)
|• Clinical Outcome Research|
|• Clinical Research Data Management|
|• Drug Delivery System Development|
|• Drug Development Services|
|• Patient Identification Cards|
|• Patient Identification System|